Search

everythinglearnresearchcommunity

for

Search:↓

A genetic marker linked to a type of hair loss was found in most patients studied.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Certain genetic variants are linked to frontal fibrosing alopecia in Spanish patients.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

Genetic differences affect COVID-19 severity and treatment effectiveness.

Oral contraceptive use may increase the risk of frontal fibrosing alopecia in women with a specific CYP1B1 gene variant.

HLA-DRB5 and other genes may be linked to alopecia universalis.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Certain genes are linked to the risk of developing Alopecia Areata.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Somatostatin may help protect hair follicles from immune attacks.

Alopecia areata causes unpredictable hair loss and requires personalized treatment.

Somatostatin helps hair follicles suppress immune responses, which might aid in treating certain hair loss conditions.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

Mercury allergy linked to specific genes may contribute to burning mouth syndrome, and silicon might play a role in maintaining healthy hair.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Different genes are linked to various types of hair loss.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

Women with excessive hair growth or polycystic ovary disease may more often carry a gene variant for 21 hydroxylase deficiency.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.